Rekrutierende Studie = ; Fortlaufende Studie = ; Förderung durch ein IRDiRC-Mitglied = ; ERN-Mitglied =

Nationale klinische Studie(n)

VEREINIGTES KONIGREICH

Greater Manchester
MANCHESTER

A Two-Period, Open-label Trial Evaluating the Efficacy and Safety of Dasiglucagon for the Treatment of Children with Congenital Hyperinsulinism

Royal Manchester Children's Hospital

Department of Endocrinology

Mehr Details

VEREINIGTES KONIGREICH

Strathclyde
GLASGOW

An Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children With Congenital Hyperinsulinism-GB

NHS Greater Glasgow and Clyde Corporate HQ

Greater Glasgow and Clyde NHS Board

Mehr Details

Multinationale klinische Studie(n)

DANEMARK

Sjælland
GLOSTRUP

An Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children With Congenital Hyperinsulinism

Zealand Pharma A/S

Mehr Details